TickerFactsScreenerDevelopers

MYRIAD GENETICS INC (MYGN) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2022: $202.00M2023: $236.20M2024: $252.20M2025: $247.90M$247.90M
2022Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$247.90M-1.7%
2024$252.20M+6.8%
2023$236.20M+16.9%
2022$202.00M—